Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes

P. Masiello, T. Locci Cubeddu, G. Frosina, E. Bergamini

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The addition of 3-aminobenzamide (a potent inhibitor of poly(ADP-ribose)synthetase) into the incubation medium, prevents streptozotocin-induced inhibition of glucose-stimulated insulin release from isolated islets [control 142±14μU·islet-1·h-1; streptozotocin (0.5mg/ml) 31±8; 3-aminobenzamide (l.0 mg/ml) 96±11; streptozotocin plus 3-aminobenzamide 122±19]. In vivo, intraperitoneal 3-aminobenzamide 300 mg/kg body weight prevents the appearance of overt diabetes in streptozotocin-treated rats. These protective effects of 3-aminobenzamide are dose-dependent and are similar to those exerted by nicotinamide. Taking into account that poly ADP-ribosylation is involved in the repair of damaged DNA, the protection exerted by 3-aminobenzamide against the diabetogenic effect of streptozotocin strongly supports the view that this acute effect may be a major consequence of the activation of DNA repair mechanisms in islet cells.

Original languageEnglish
Pages (from-to)683-686
Number of pages4
JournalDiabetologia
Volume28
Issue number9
DOIs
Publication statusPublished - Sep 1985

Fingerprint

Poly Adenosine Diphosphate Ribose
Experimental Diabetes Mellitus
Ligases
Streptozocin
DNA Repair
Niacinamide
Islets of Langerhans
Adenosine Diphosphate
3-aminobenzamide
Body Weight
Insulin
Glucose

Keywords

  • 3-aminobenzamide
  • Experimental diabetes
  • immunoreactive insulin
  • insulin release
  • isolated islets
  • nicotinamide
  • poly(ADP-ibose)synthetase inhibitors
  • streptozotocin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes. / Masiello, P.; Cubeddu, T. Locci; Frosina, G.; Bergamini, E.

In: Diabetologia, Vol. 28, No. 9, 09.1985, p. 683-686.

Research output: Contribution to journalArticle

@article{1b97920638fe45aaa08eee0dfac857b8,
title = "Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes",
abstract = "The addition of 3-aminobenzamide (a potent inhibitor of poly(ADP-ribose)synthetase) into the incubation medium, prevents streptozotocin-induced inhibition of glucose-stimulated insulin release from isolated islets [control 142±14μU·islet-1·h-1; streptozotocin (0.5mg/ml) 31±8; 3-aminobenzamide (l.0 mg/ml) 96±11; streptozotocin plus 3-aminobenzamide 122±19]. In vivo, intraperitoneal 3-aminobenzamide 300 mg/kg body weight prevents the appearance of overt diabetes in streptozotocin-treated rats. These protective effects of 3-aminobenzamide are dose-dependent and are similar to those exerted by nicotinamide. Taking into account that poly ADP-ribosylation is involved in the repair of damaged DNA, the protection exerted by 3-aminobenzamide against the diabetogenic effect of streptozotocin strongly supports the view that this acute effect may be a major consequence of the activation of DNA repair mechanisms in islet cells.",
keywords = "3-aminobenzamide, Experimental diabetes, immunoreactive insulin, insulin release, isolated islets, nicotinamide, poly(ADP-ibose)synthetase inhibitors, streptozotocin",
author = "P. Masiello and Cubeddu, {T. Locci} and G. Frosina and E. Bergamini",
year = "1985",
month = "9",
doi = "10.1007/BF00291976",
language = "English",
volume = "28",
pages = "683--686",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes

AU - Masiello, P.

AU - Cubeddu, T. Locci

AU - Frosina, G.

AU - Bergamini, E.

PY - 1985/9

Y1 - 1985/9

N2 - The addition of 3-aminobenzamide (a potent inhibitor of poly(ADP-ribose)synthetase) into the incubation medium, prevents streptozotocin-induced inhibition of glucose-stimulated insulin release from isolated islets [control 142±14μU·islet-1·h-1; streptozotocin (0.5mg/ml) 31±8; 3-aminobenzamide (l.0 mg/ml) 96±11; streptozotocin plus 3-aminobenzamide 122±19]. In vivo, intraperitoneal 3-aminobenzamide 300 mg/kg body weight prevents the appearance of overt diabetes in streptozotocin-treated rats. These protective effects of 3-aminobenzamide are dose-dependent and are similar to those exerted by nicotinamide. Taking into account that poly ADP-ribosylation is involved in the repair of damaged DNA, the protection exerted by 3-aminobenzamide against the diabetogenic effect of streptozotocin strongly supports the view that this acute effect may be a major consequence of the activation of DNA repair mechanisms in islet cells.

AB - The addition of 3-aminobenzamide (a potent inhibitor of poly(ADP-ribose)synthetase) into the incubation medium, prevents streptozotocin-induced inhibition of glucose-stimulated insulin release from isolated islets [control 142±14μU·islet-1·h-1; streptozotocin (0.5mg/ml) 31±8; 3-aminobenzamide (l.0 mg/ml) 96±11; streptozotocin plus 3-aminobenzamide 122±19]. In vivo, intraperitoneal 3-aminobenzamide 300 mg/kg body weight prevents the appearance of overt diabetes in streptozotocin-treated rats. These protective effects of 3-aminobenzamide are dose-dependent and are similar to those exerted by nicotinamide. Taking into account that poly ADP-ribosylation is involved in the repair of damaged DNA, the protection exerted by 3-aminobenzamide against the diabetogenic effect of streptozotocin strongly supports the view that this acute effect may be a major consequence of the activation of DNA repair mechanisms in islet cells.

KW - 3-aminobenzamide

KW - Experimental diabetes

KW - immunoreactive insulin

KW - insulin release

KW - isolated islets

KW - nicotinamide

KW - poly(ADP-ibose)synthetase inhibitors

KW - streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=0022360561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022360561&partnerID=8YFLogxK

U2 - 10.1007/BF00291976

DO - 10.1007/BF00291976

M3 - Article

VL - 28

SP - 683

EP - 686

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 9

ER -